Skip to main content
. 2021 Sep 16;33(6):648–657. doi: 10.1097/CCO.0000000000000792

FIGURE 1.

FIGURE 1

Biological aging and multiple myeloma. (a) Biological process of aging and senescence in multiple myeloma patients. CT, computer tomography; DXA, imaging like dual-energy X-ray absorptiometry; SASP, senescence-associated secretory phenotype; TUG, time up and go test. (b) Frailty measures and biomarkers of aging in multiple myeloma patients. Adapted with permission from Soto Perez de Celis, Lancet Oncol, 2018; Cook, Leukemia, 2020. Adapted with permission from Dr A. Rosko's pivotal work/slides and American Federation for Aging Research (AFAR).